JCR Pharmaceuticals and Modalis Therapeutics Announce Transition to the Next Phase of Joint ...
JCR Pharmaceuticals Co., Ltd. (TOKYO:4552; "JCR") and Modalis Therapeutics Corporation (TOKYO:4883; "Modalis") today ...